Publications by authors named "M Schiavini"
A Delphi consensus-seeking procedure was conducted to validate a list of ICD-9-CM codes that could help identify hospital admissions in which antimicrobials are more likely to be prescribed. The panel agreed to include 2967 codes out of 16229 (18.28%).
View Article and Find Full Text PDFArticle Synopsis
- - The study examines how early treatments for COVID-19 affect the duration of virus shedding in high-risk individuals with mild symptoms.
- - Conducted at Luigi Sacco Hospital, the research involved 518 participants, revealing that early treatment significantly shortened viral shedding and reduced the likelihood of hospitalization and pneumonia.
- - The findings suggest that early interventions are essential for better health outcomes and resource management during the pandemic, with conditions like COPD influencing treatment effectiveness.
Article Synopsis
- * A study conducted at Luigi Sacco Hospital from May 2021 to September 2023 reviewed 1802 VAD placements, identifying 54 CRBSI cases, with Candida spp. detected in about 30% of those infections, indicating a prevalence of 3.05%.
- * The findings revealed a concerning link between Candida spp. CRBSIs and higher rates of COVID-19
This retrospective observational study investigates the impact of early COVID-19 therapies, including antivirals and monoclonal antibodies (mAbs), on time to achieve negative swab results in high-risk outpatients infected with specific Omicron sublineages. The study enrolled 104 patients from Luigi Sacco Hospital in Milan between December 2021 and March 2023, categorizing them based on the Omicron sublineage they were infected with (BA.1, BA.
View Article and Find Full Text PDFPurpose: Besides the well-established efficacy in preventing severe COVID-19, the impact of early treatments, namely antivirals and monoclonal antibodies (mAbs), on the time length to negativization of SARS-CoV-2 nasal swabs is still unclear. The aim of this study was to compare the efficacy of different early treatments in reducing the SARS-CoV-2 viral shedding, identifying a single drug that might potentially lead to a more rapid negativization of SARS-CoV-2 nasal swab.
Methods: This was a single-centre, retrospective, observational study conducted at Ospedale Luigi Sacco in Milan.